Document is current
Any future updates will be listed below
-
Authors
Carson, Emma-Kate https://orcid.org/0000-0001-9684-0247
Dhillon, Haryana M.
Vardy, Janette L.
Brown, Chris
Nunes-Zlotkowski, Kelly Ferrao
Della-Fiorentina, Stephen
Khan, Sarah
Parsonson, Andrew
Roncoloato, Felicia
Pearson, Antonia
Barnes, Tristan
Kiely, Belinda E.
-
Funding
Funding for this research was provided by:
University of Sydney
- License Information
-
More Information
Article History
Received: 15 January 2024
Accepted: 7 May 2024
First Online: 23 May 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Institutional Human Research Ethics Committee protocol number HREC/14/CRGH/23). The study was approved by the Sydney Local Health District – Concord Zone Health Research Ethics Committee for all sites (CH62/6/2020–018), with governance approved at all participating sites.
: Informed consent was obtained from all individual participants included in the study.
: Informed consent to have de-identified data published was obtained from all individual participants included in the study.
: Author EC has received speaker honoraria from Eli Lilly. Author BK has received speaker honoraria from Novartis, Eisai, MSD and Gilead, travel support from Novartis, Pfizer and MSD, and honoraria for serving on advisory boards for Novartis and Gilead. Author TB has received travel support from GSK and Novartis. Author HD, JV, CB, KNZ, SDF, SK, AP, FR, and AP declare they have no financial interests. The authors have no relevant non-financial interests to disclose.
